Autoimmunity in Inner Ear Disease

NCT00000361 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

NIH

Sponsor class

Conditions

Hearing Loss, Sensorineural

Interventions

DRUG: Corticosteroids
DRUG: Methotrexate

Sponsor

National Institute on Deafness and Other Communication Disorders (NIDCD)